Literature DB >> 15193028

CGH pattern of esthesioneuroblastoma and their metastases.

Ulrike Bockmühl1, Xuejun You, Manuela Pacyna-Gengelbach, Hartmut Arps, Wolfgang Draf, Iver Petersen.   

Abstract

Comparative genomic hybridization (CGH) was used to screen 22 esthesioneuroblastomas (ENB) from 12 patients including 12 primary tumors and 10 metastasis/recurrent lesions for chromosomal imbalances being the most extensive study so far. The analysis revealed a characteristic pattern consisting of deletions on chromosomes 3p and overrepresentations on 17q in up to 100% of cases. Other important alterations being detectable in more than 80% of cases were deletions on 1p, 3p/q, 9p, 10p/q along with overrepresentation on 17p13, 20p and 22q. Particularly striking was the pattern for chromosomes 3, 10 and 17q and 20 being affected almost exclusively by deletions or overrepresentations, respectively. Pronounced overrepresentations suggestive for high copy amplifications were seen on 1p34, 1q23-q31, 7p21, 7q31, 9p23-p24, 17q11-q22, 17q24-q25, 19, 20p, 20q13 and 22q13. Comparing tumor pairs from the same patient revealed a high concordance indicating clonality and confirming the genetic homogeneity of the tumor entity. The analysis of metastatic/recurrent lesions indicated a higher percentage of pronounced alterations, e.g., high copy DNA gains at 1q34-qter, 7q11, 9p23-p24, 9q34, 13q33-q34, 16p13.3, 16p11, 16q23-q24 and 17p13. The analysis furthermore suggested specific alterations, e.g., deletions of chromosome 11 and gains of 1p to be associated with metastasis formation and/or worse prognosis. Our results indicate that ENB is a distinct entity and provides criteria for its genetic distinction from other small round cell tumor types.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15193028     DOI: 10.1111/j.1750-3639.2004.tb00048.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  19 in total

1.  Tracing the tumor lineage.

Authors:  Nicholas E Navin; James Hicks
Journal:  Mol Oncol       Date:  2010-05-05       Impact factor: 6.603

Review 2.  Genomic screening of head and neck cancer and its implications for therapy planning.

Authors:  Jan Akervall
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-03-31       Impact factor: 2.503

Review 3.  Sinonasal Neuroendocrine Neoplasms: Current Challenges and Advances in Diagnosis and Treatment, with a Focus on Olfactory Neuroblastoma.

Authors:  Diana Bell
Journal:  Head Neck Pathol       Date:  2018-02-09

Review 4.  Olfactory Neuroblastoma.

Authors:  Ahmed S Abdelmeguid
Journal:  Curr Oncol Rep       Date:  2018-02-07       Impact factor: 5.075

5.  Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional Treatment Options.

Authors:  Laurie M Gay; Sungeun Kim; Kyle Fedorchak; Madappa Kundranda; Yazmin Odia; Chaitali Nangia; James Battiste; Gerardo Colon-Otero; Steven Powell; Jeffery Russell; Julia A Elvin; Jo-Anne Vergilio; James Suh; Siraj M Ali; Philip J Stephens; Vincent A Miller; Jeffrey S Ross
Journal:  Oncologist       Date:  2017-05-11

6.  Biological resonance for cancer metastasis, a new hypothesis based on comparisons between primary cancers and metastases.

Authors:  Dongwei Gao; Sha Li
Journal:  Cancer Microenviron       Date:  2013-11-10

7.  The role of elective nodal irradiation for esthesioneuroblastoma patients with clinically negative neck.

Authors:  Wen Jiang; Abdallah S R Mohamed; Clifton David Fuller; Betty Y S Kim; Chad Tang; G Brandon Gunn; Ehab Y Hanna; Steven J Frank; Shirley Y Su; Eduardo Diaz; Michael E Kupferman; Beth M Beadle; William H Morrison; Heath Skinner; Stephen Y Lai; Adel K El-Naggar; Franco DeMonte; David I Rosenthal; Adam S Garden; Jack Phan
Journal:  Pract Radiat Oncol       Date:  2015-11-10

Review 8.  Rhabdomyoblastic Differentiation in Head and Neck Malignancies Other Than Rhabdomyosarcoma.

Authors:  Justin A Bishop; Lester D R Thompson; Antonio Cardesa; Leon Barnes; James S Lewis; Asterios Triantafyllou; Henrik Hellquist; Goran Stenman; Jennifer L Hunt; Michelle D Williams; Pieter J Slootweg; Kenneth O Devaney; Douglas R Gnepp; Bruce M Wenig; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck Pathol       Date:  2015-03-11

9.  Esthesioneuroblastoma - a clinicopathologic study and role of DNA topoisomerase alpha.

Authors:  Suash Sharma; Mehar C Sharma; Maribeth H Johnson; Mimi Lou; Alok Thakar; Chitra Sarkar
Journal:  Pathol Oncol Res       Date:  2007-07-03       Impact factor: 3.201

10.  Identification and validation of dysregulated metabolic pathways in metastatic renal cell carcinoma.

Authors:  Nicole M A White; Daniel W Newsted; Olena Masui; Alexander D Romaschin; K W Michael Siu; George M Yousef
Journal:  Tumour Biol       Date:  2013-10-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.